Home » Topics » Coronavirus, BioWorld

Coronavirus, BioWorld
RSS

Alios Closes $32M Series A Round, Adds New Investor

June 12, 2009

By Jennifer Boggs

Biotechs Skyrocket as Swine Flu Deemed Public Emergency

April 28, 2009

By Jennifer Boggs

Other News To Note

July 18, 2007

Targeting Immunity, Not Invader, Key To Broad-Spectrum Antiviral

June 26, 2007

By Anette Breindl

Other News To Note

June 26, 2007

For Replikins, Replication Data Allow For Predicting Epidemics

April 27, 2006

By Jennifer Boggs

Other News To Note

Feb. 2, 2006

AVI Brings In $23M For Third-Generation Antisense Drugs

Nov. 16, 2005

Other News To Note

Nov. 3, 2005

Collaborations Between Biotech And Pharmaceutical Companies: Aug. 19-Oct. 19, 2005

Oct. 24, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...